Tilsed et al. (2024) “IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation” PNAS.
DOI: 10.1073/pnas.2319856121
Read about Tilsed et al. (2024) “IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation” PNAS.
Birdsall et al. (2024) “Monitoring stability indicating impurities and aldehyde content in lipid nanoparticle raw material and formulated drugs” Journal of ChromatographyB.
DOI: 10.1016/j.jchromb.2024.124005
Read about Birdsall et al. (2024) “Monitoring stability indicating impurities and aldehyde content in lipid nanoparticle raw material and formulated drugs” Journal of ChromatographyB.
Acuitas Therapeutics Named One of BC’s Top Employers of 2024
Read about Acuitas Therapeutics Named One of BC’s Top Employers of 2024
Matias et al. (2024) “mRNA vaccination of rabbits alters the fecundity, but not the attachment, of adult Ixodes scapularis” Scientific Reports.
DOI: 10.1038/s41598-023-50389-6
Read about Matias et al. (2024) “mRNA vaccination of rabbits alters the fecundity, but not the attachment, of adult Ixodes scapularis” Scientific Reports.
Kunkeaw et al. (2023) “A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax” NPJ Vaccines.
DOI: 10.1038/s41541-023-00786-9
Read about Kunkeaw et al. (2023) “A Pvs25 mRNA vaccine induces complete and durable transmission-blocking immunity to Plasmodium vivax” NPJ Vaccines.
Breda et al. (2023) “In vivo hematopoietic stem cell modification by mRNA delivery” Science.
DOI: 10.1126/science.ade6967
Read about Breda et al. (2023) “In vivo hematopoietic stem cell modification by mRNA delivery” Science.
Hoffmann et al. (2023) “ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines” Cell.
DOI: 10.1016/j.cell.2023.04.024
Read about Hoffmann et al. (2023) “ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines” Cell.
Gál et al. (2023) “Restoration of motor function through delayed intraspinal delivery of human IL-10-encoding nucleoside-modified mRNA after spinal cord injury” Research.
DOI: 10.34133/research.0056
Read about Gál et al. (2023) “Restoration of motor function through delayed intraspinal delivery of human IL-10-encoding nucleoside-modified mRNA after spinal cord injury” Research.
Connors et al. (2023) “Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals” Communications Biology.
DOI: 10.1038/s42003-023-04555-1
Read about Connors et al. (2023) “Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals” Communications Biology.
Schiepers et al. (2023) “Molecular fate-mapping of serum antibody responses to repeat immunization” Nature.
DOI: 10.1038/s41586-023-05715-3
Read about Schiepers et al. (2023) “Molecular fate-mapping of serum antibody responses to repeat immunization” Nature.
Arevalo et al. (2022) “A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes” Science.
DOI: 10.1126/science.abm0271
Read about Arevalo et al. (2022) “A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes” Science.
Gorsuch et al. (2022) “Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo” Molecular Therapy.
DOI: 10.1016/j.ymthe.2022.05.013
Read about Gorsuch et al. (2022) “Targeting the Hepatitis B cccDNA with a Sequence-Specific ARCUS Nuclease to Eliminate Hepatitis B Virus In Vivo” Molecular Therapy.